Correlation Between Zivo Bioscience and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Zivo Bioscience and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Cyclacel Pharmaceuticals.
Diversification Opportunities for Zivo Bioscience and Cyclacel Pharmaceuticals
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Zivo and Cyclacel is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Cyclacel Pharmaceuticals
If you would invest 181.00 in Zivo Bioscience on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Zivo Bioscience or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 2.44% |
| Values | Daily Returns |
Zivo Bioscience vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Cyclacel Pharmaceuticals |
Zivo Bioscience and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zivo Bioscience and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Zivo Bioscience and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |